GlassScriptPhysician profile
Haley Elizabeth Wagner
NPI 1184341323
$2,017.42
in general payments reported to CMS, 2019-2025
19 companies · $657 in 2025
The $657 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $568 · 2024: $793 · 2025: $657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,017.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,017.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $320.46 | 2023-2025 | Mounjaro, Zepbound, Trulicity |
| Pfizer INC. | $253.37 | 2023-2025 | |
| Glaxosmithkline, LLC. | $230.26 | 2023-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $223.10 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $218.63 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $214.01 | 2023-2025 | Airsupra, Breztri, Farxiga |
| Exact Sciences Corporation | $137.79 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amgen INC. | $98.75 | 2023-2024 | Repatha, Krystexxa, Otezla |
| Merck Sharp & Dohme LLC | $64.92 | 2023-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Xeris Pharmaceuticals, INC. | $52.48 | 2025 | Gvoke Hypopen |
| Sanofi Pasteur INC. | $36.64 | 2023-2024 | |
| Corcept Therapeutics | $36.52 | 2024 | Korlym |
| Ardelyx, INC. | $24.55 | 2025 | Ibsrela |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.08 | 2025 | Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $18.98 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $18.36 | 2024 | Inspire |
| Gilead Sciences, INC. | $16.72 | 2023 | |
| Phathom Pharmaceuticals, INC. | $15.65 | 2025 | Voquezna |
| Tactile Systems Technology INC | $13.15 | 2023 | Flexitouch Plus, Entre Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Wagner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.